These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22583164)

  • 1. Willingness to pay and quality of life in patients with rosacea.
    Beikert FC; Langenbruch AK; Radtke MA; Augustin M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):734-8. PubMed ID: 22583164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay and quality of life in patients with atopic dermatitis.
    Beikert FC; Langenbruch AK; Radtke MA; Kornek T; Purwins S; Augustin M
    Arch Dermatol Res; 2014 Apr; 306(3):279-86. PubMed ID: 23982630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay.
    Huang Y; Yan S; Xie H; Wang B; Zhao Z; Huang Y; Li J
    Patient Prefer Adherence; 2022; 16():659-670. PubMed ID: 35283624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological Burden and Willingness to Pay Among Korean Rosacea Patients and Their Association With Rosacea Phenotype and Severity: A Multi-Center Cross-Sectional Study.
    Woo YR; Kim S; Cho SH; Kim HS
    J Cutan Med Surg; 2023 Nov; 27(6):601-607. PubMed ID: 37587799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quality of life impact of acne and rosacea compared to other major medical conditions.
    Cresce ND; Davis SA; Huang WW; Feldman SR
    J Drugs Dermatol; 2014 Jun; 13(6):692-7. PubMed ID: 24918559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of skin disorders associated with facial discoloration on quality of life: Novel insights explaining discordance between life quality scores and willingness to pay.
    Yang TT; Lan CE
    J Cosmet Dermatol; 2022 Jul; 21(7):3053-3058. PubMed ID: 34706154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
    Oh DY; Crawford B; Kim SB; Chung HC; McDonald J; Lee SY; Ko SK; Ro J
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):282-91. PubMed ID: 22898238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life among Malaysian patients with vitiligo.
    Wong SM; Baba R
    Int J Dermatol; 2012 Feb; 51(2):158-61. PubMed ID: 22250623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Willingness to pay and quality of life in patients with Japanese-cedar pollinosis].
    Kakutani C; Ogino S; Irifune M; Takeda M; Baba K
    Arerugi; 2003 Jan; 52(1):7-14. PubMed ID: 12598717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness-to-Pay and Benefit-Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China.
    Deng Q; Zhang SP; Deng YX; Liu FF; Shi W; Xie HF; Xiao Y; Huang YX; Li J
    Patient Prefer Adherence; 2020; 14():1843-1852. PubMed ID: 33116428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and rosacea: pulsed dye laser impact.
    Menezes N; Moreira A; Mota G; Baptista A
    J Cosmet Laser Ther; 2009 Sep; 11(3):139-41. PubMed ID: 19462330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychological impact of rosacea and the influence of current management options.
    Moustafa F; Lewallen RS; Feldman SR
    J Am Acad Dermatol; 2014 Nov; 71(5):973-80. PubMed ID: 24993600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.
    Yang X; Ouyang Y; Deng Y; Xiao Y; Tang Y; Jian D; Li J; Xie H; Huang Y
    Patient Prefer Adherence; 2021; 15():1197-1205. PubMed ID: 34113082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.